May 31, 2024
Institutional Review Board, Hospital for Special Surgery
The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.
For further information, see Understanding Clinical Trials/Research Studies.
Fernando J. Quevedo González, PhD
David J Mayman,MD
Jonathan M Vigdorchik,MD
Eytan M Debbi, MD, PhD
Timothy M Wright, PhD
Joseph D Lipman, MS
Theofilos Karasavvidis
Michael Parides, PhD
Cale Pagan
This study will utilize pre and postoperative CT-scans of total knee arthroplasty patients to quantify the implant motion after surgery. Implant motion has been suggested as an early indicator of the longevity of implant fixation and could be also related to joint laxity. We will enroll 30 patients scheduled for total knee arthroplasty. Patients will receive CT-scans preoperatively, prior to discharge, and at 6 weeks, 6 months, and 1 year postoperatively to measure the motion of the implant.
Study will consider all patients between 18 and 90 years of age, scheduled for primary total knee arthroplasty. Patients will be excluded if metal hardware is present on either knee, if they are wheelchair bound, or have neurological conditions
Fernando J Quevedo Gonzalez, MD
quevedogonzalezf@hss.edu
646.797.8276